ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF

This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MANCHADO ROBLES Eusebio, FESSLER Boris, IYER Shwetha, BUNTIN Kathrin, HAINZL Dominik, ROMANET Vincent, BLUEMMEL Anne - Sophie, FAN Liqiong, YERRAMILLI-RAO Padmaja, WUERSCH Kuno, KHERA Eshita, MAUDENS Pierre, D''ALESSIO Joseph Anthony, RAMOT Roee, PISTORIUS Dominik, GABRIEL Doris, HOFFMASTER Keith
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor and methods of treating or preventing cancer using the formulations. Esta solicitud desvela microorganismos y métodos de producción de inhibidores de GNAQ/GNA11 y métodos de fabricación de conjugados anticuerpo-fármaco de anticuerpos anti-PMEL17 o fragmentos de unión a antígeno conjugados con un inhibidor de GNAQ/GNA11. La divulgación también se refiere a formulaciones que comprenden conjugados anticuerpo-fármaco de anticuerpos anti-PMEL17 o fragmentos de unión a antígeno conjugados con un inhibidor de GNAQ/GNA11 y métodos de tratamiento o prevención del cáncer usando las formulaciones.